Getein Biotech Statistics

Total Valuation

Getein Biotech has a market cap or net worth of CNY 4.08 billion. The enterprise value is 3.79 billion.

Market Cap	4.08B
Enterprise Value	3.79B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Getein Biotech has 507.15 million shares outstanding. The number of shares has decreased by -0.29% in one year.

Current Share Class	n/a
Shares Outstanding	507.15M
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	-0.37%
Owned by Insiders (%)	41.24%
Owned by Institutions (%)	2.16%
Float	280.45M

Valuation Ratios

The trailing PE ratio is 16.09.

PE Ratio	16.09
Forward PE	n/a
PS Ratio	3.27
PB Ratio	1.47
P/TBV Ratio	1.68
P/FCF Ratio	14.30
P/OCF Ratio	9.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.34, with an EV/FCF ratio of 13.29.

EV / Earnings	14.98
EV / Sales	3.04
EV / EBITDA	11.34
EV / EBIT	16.62
EV / FCF	13.29

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.26.

Current Ratio	1.90
Quick Ratio	1.50
Debt / Equity	0.26
Debt / EBITDA	2.14
Debt / FCF	2.50
Interest Coverage	15.30

Financial Efficiency

Return on equity (ROE) is 9.52% and return on invested capital (ROIC) is 4.11%.

Return on Equity (ROE)	9.52%
Return on Assets (ROA)	3.70%
Return on Invested Capital (ROIC)	4.11%
Return on Capital Employed (ROCE)	7.96%
Revenue Per Employee	497,618
Profits Per Employee	100,872
Employee Count	2,508
Asset Turnover	0.32
Inventory Turnover	1.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.90% in the last 52 weeks. The beta is 0.34, so Getein Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-7.90%
50-Day Moving Average	8.41
200-Day Moving Average	8.18
Relative Strength Index (RSI)	44.51
Average Volume (20 Days)	5,137,576

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Getein Biotech had revenue of CNY 1.25 billion and earned 252.99 million in profits. Earnings per share was 0.50.

Revenue	1.25B
Gross Profit	850.23M
Operating Income	227.97M
Pretax Income	284.89M
Net Income	252.99M
EBITDA	326.51M
EBIT	227.97M
Earnings Per Share (EPS)	0.50

Full Income Statement

Balance Sheet

The company has 1.17 billion in cash and 713.35 million in debt, giving a net cash position of 457.88 million or 0.90 per share.

Cash & Cash Equivalents	1.17B
Total Debt	713.35M
Net Cash	457.88M
Net Cash Per Share	0.90
Equity (Book Value)	2.77B
Book Value Per Share	5.12
Working Capital	963.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 436.62 million and capital expenditures -151.41 million, giving a free cash flow of 285.21 million.

Operating Cash Flow	436.62M
Capital Expenditures	-151.41M
Free Cash Flow	285.21M
FCF Per Share	0.56

Full Cash Flow Statement

Margins

Gross margin is 68.13%, with operating and profit margins of 18.27% and 20.27%.

Gross Margin	68.13%
Operating Margin	18.27%
Pretax Margin	22.83%
Profit Margin	20.27%
EBITDA Margin	26.16%
EBIT Margin	18.27%
FCF Margin	22.85%

Dividends & Yields

This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 2.25%.

Dividend Per Share	0.18
Dividend Yield	2.25%
Dividend Growth (YoY)	-52.50%
Years of Dividend Growth	n/a
Payout Ratio	43.53%
Buyback Yield	0.29%
Shareholder Yield	2.54%
Earnings Yield	6.20%
FCF Yield	6.99%

Dividend Details

Stock Splits

The last stock split was on June 8, 2022. It was a forward split with a ratio of 1.4.

Last Split Date	Jun 8, 2022
Split Type	Forward
Split Ratio	1.4

Scores

Getein Biotech has an Altman Z-Score of 3.87.

Altman Z-Score	3.87
Piotroski F-Score	n/a